Godfrey K

Department of Brain Sciences, Imperial College London, UK.

3 preprints · 15 papers · ORCID

PreprintKetamine

Neurite Complexity and Plasticity Markers Track Synaptic Vesicle Density in the Living Human Brain: A Multimodal PET-MRI-EEG Study

Agnorelli C, Peill J, Kurtin DL +25

Europe PMC2026
ArticlePsilocybin

No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study.

Bailey NW, Webb SL, Fitzgibbon BM +13

Europe PMC2026
ArticlePsilocybin

Psilocybin therapy for adult females with anorexia nervosa: pilot study.

Douglass HM, Spriggs MJ, Godfrey K +17

Europe PMC2026
ArticlePsilocybin

Human brain changes after first psilocybin use.

Lyons T, Spriggs M, Kerkelä L +20

Europe PMC2026
ArticleKetamine

Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.

Agnorelli C, Peill J, Sawicka G +18

Europe PMC2026
ArticlePsilocybin

Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.

Pellegrini L, Fineberg NA, O'Connor S +11

Europe PMC2025
PreprintKetamine

Detecting neuroplastic effects induced by ketamine in healthy human subjects: a multimodal approach

Agnorelli C, Peill J, Sawicka G +16

Europe PMC2025
ArticlePsilocybin

Effects of psychedelics on human oscillatory brain activity.

Godfrey K, Luan LX, Timmermann C

Europe PMC2025
ArticlePsilocybin

Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.

Agnorelli C, Spriggs M, Godfrey K +8

Europe PMC2025
ArticlePsilocybin

Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.

O'Connor S, Godfrey K, Reed S +17

Europe PMC2025
ArticleKetamine

Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings.

Agnorelli C, Cinti A, Barillà G +12

Europe PMC2025
ArticlePsilocybin

An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.

Godfrey K, Weiss B, Zhang X +5

Europe PMC2025
PreprintPsilocybin

Human brain changes after first psilocybin use

Lyons T, Spriggs M, Kerkelä L +20

Europe PMC2024
ArticleLSD

Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide.

Murphy RJ, Sumner RL, Godfrey K +4

Europe PMC2025
ArticlePsilocybin

Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".

Bornemann J, Close JB, Ahmad K +6

Europe PMC2024
ArticleLSD

Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial.

Murphy RJ, Godfrey K, Shaw AD +2

Europe PMC2024
ArticlePsilocybin

Psilocybin and Other Classic Psychedelics in Depression.

Nutt DJ, Peill JM, Weiss B +3

Europe PMC2024
ArticleLSD

Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial.

Murphy RJ, Sumner R, Evans W +10

Europe PMC2023